Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 24, 2010

Texas Cancer Prevention Organization Awards Rice University $3.7M for Cancer Diagnostic Bio-Nano-Chip

  • Rice University researchers have been awarded a $3.7 million grant by the Cancer Prevention and Research Institute of Texas to further develop and commercialize a bioprocessor-driven diagnostic Bio-Nano-Chip for cancer applications.

    The chip is designed to be programmable for identifying specific biomarkers in body fluids that could help rapidly diagnose diseases such as cancer, HIV, and heart disease, claims the Rice team led by John McDevitt, Ph.D., Brown-Wiess professor in bioengineering and chemistry and head of the bioscience research collaborative laboratory.

    Separate human trials with the new chip are already ongoing to identify markers of heart attack and oral cancer. Professor McDevitt says he hopes the technology may one day be used by emergency medical technicians to help diagnose patients either at the site of call-out or in the ambulance.


Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »